Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase Iii Studies (Sign Trials) (Nov, 10.1007/S10803-020-04709-8, 2020)

AuthID
 P-00T-C05
15
Author(s)
Crutel, V
·
Lambert, E
·
Penelaud, PF
·
Severo, CA
·
Fuentes, J
·
Rosier, A
·
Hervas, A
·
Marret, S
·
Oliveira, G
·
Parellada, M
·
Gouttefangeas, S
·
Bertrand, M
·
Ravel, D
·
Falissard, B
Document Type
Correction
Year published
2021
Published
in JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, ISSN: 0162-3257
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000606353900002
Source Identifiers
ISSN: 0162-3257
Export Publication Metadata
Marked List
 Add to Marked List
Info
At this moment we don't have any links to full text documens.

A place for researchers and their institutions

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service